Trials / Completed
CompletedNCT04223830
Initial Case Series With Exalt Single-Use Duodenoscope - Expanded User Experience
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to confirm procedural performance of the Exalt Model D Single-Use Duodenoscope in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and other duodenoscope-based procedures.
Detailed description
The main objective of this study to confirm the design and operating specifications of the Exalt Model D Single-Use Duodenoscope in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and other duodenoscope-based procedures in study subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Exalt Model D Single-Use Duodenoscope | Subjects will have a clinically indicated per standard of care endoscopic retrograde cholangiopancreatography (ERCP) or other duodenoscope-based procedure performed with the Exalt single use duodenoscope study device. |
Timeline
- Start date
- 2020-01-14
- Primary completion
- 2021-02-22
- Completion
- 2021-03-01
- First posted
- 2020-01-10
- Last updated
- 2022-03-31
- Results posted
- 2022-03-31
Locations
7 sites across 2 countries: United States, Netherlands
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04223830. Inclusion in this directory is not an endorsement.